Try Fund Library Premium
For Free with a 30 day trial!
Alternative Equity Focus
Click for more information on Fundata’s FundGrade.
NAVPS (04-02-2025) |
$2.87 |
---|---|
Change |
$0.14
(5.10%)
|
As at February 28, 2025
Inception Return (December 18, 2020): -23.11%
Row Heading | Return | Annualized Return | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
Fund | -11.94% | -19.79% | -25.41% | -9.31% | -41.51% | -24.72% | -24.88% | -28.58% | - | - | - | - | - | - |
Benchmark | -0.40% | -0.31% | 10.31% | 3.06% | 22.45% | 15.63% | 9.72% | 12.23% | 12.73% | 11.38% | 10.72% | 9.76% | 11.18% | 8.50% |
Category Average | -0.84% | -0.33% | 4.81% | 1.46% | 11.65% | 11.56% | 6.63% | 7.25% | 8.98% | - | - | - | - | - |
Category Rank | 230 / 237 | 219 / 222 | 204 / 205 | 226 / 231 | 189 / 190 | 149 / 150 | 129 / 129 | 101 / 101 | - | - | - | - | - | - |
Quartile Ranking | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | - | - | - | - | - | - |
Return % | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fund | -7.29% | -12.96% | -6.93% | -6.44% | 20.87% | -7.68% | -7.02% | 0.34% | -0.32% | -11.56% | 2.98% | -11.94% |
Benchmark | 4.14% | -1.82% | 2.77% | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% | 6.37% | -3.27% | 3.48% | -0.40% |
22.89% (December 2023)
-15.24% (April 2022)
Return % | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Fund | - | - | - | - | - | - | -14.80% | -36.06% | -9.41% | -28.82% |
Benchmark | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% | 21.65% |
Category Average | - | - | - | - | - | 5.11% | 17.27% | -5.96% | 6.54% | 16.58% |
Quartile Ranking | - | - | - | - | - | - | 4 | 4 | 4 | 4 |
Category Rank | - | - | - | - | - | - | 101/ 101 | 119/ 124 | 137/ 147 | 166/ 167 |
-9.41% (2023)
-36.06% (2022)
Next Edge Biotech and Life Sciences Opportunities Fund Class A1
Median
Other - Alternative Equity Focus
Standard Deviation | 31.51% | - | - |
---|---|---|---|
Beta | 1.09% | - | - |
Alpha | -0.35% | - | - |
Rsquared | 0.23% | - | - |
Sharpe | -0.87% | - | - |
Sortino | -1.15% | - | - |
Treynor | -0.25% | - | - |
Tax Efficiency | - | - | - |
Volatility |
|
- | - |
Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
---|---|---|---|---|
Standard Deviation | 32.16% | 31.51% | - | - |
Beta | 2.02% | 1.09% | - | - |
Alpha | -0.90% | -0.35% | - | - |
Rsquared | 0.45% | 0.23% | - | - |
Sharpe | -1.62% | -0.87% | - | - |
Sortino | -1.88% | -1.15% | - | - |
Treynor | -0.26% | -0.25% | - | - |
Tax Efficiency | - | - | - | - |
Start Date | December 18, 2020 |
---|---|
Instrument Type | Mutual Fund (Alternative) |
Share Class | Commission Based Advice |
Legal Status | Trust |
Sales Status | Open |
Currency | CAD |
Distribution Frequency | Annual |
Assets ($mil) | - |
FundServ Code | Load Code | Sales Status |
---|---|---|
NEC216 |
The Fund seeks short and long-term capital appreciation through the ownership of biotechnology and life sciences companies. Investments by the Fund may be made globally. The Fund may use leverage through the use of cash borrowings, short sales and derivatives.
The portfolio manager uses the following investment strategies to achieve the Fund’s objective: Holdings will be comprised of a mix of biotechnology and life sciences companies; Sector exposure will include biotechnology, Speciality Pharma, Medical Devices, Medical Software and Technology, Diagnostics, Drug Delivery, Bioinformatics and Agricultural, Healthcare Services and Telehealth Services; Derivatives may be used for hedging purposes, to generate income and return enhancement.
Portfolio Manager |
Next Edge Capital Corp. |
---|---|
Sub-Advisor |
- |
Fund Manager |
Next Edge Capital Corp. |
---|---|
Custodian |
- |
Registrar |
- |
Distributor |
- |
RSP Eligible | Yes |
---|---|
PAC Allowed | No |
PAC Initial Investment | - |
PAC Subsequent | - |
SWP Allowed | No |
SWP Min Balance | - |
SWP Min Withdrawal | - |
MER | 2.03% |
---|---|
Management Fee | 1.00% |
Load | Back Fee Only |
FE Max | 3.00% |
DSC Max | - |
Trailer Fee Max (FE) | 1.00% |
Trailer Fee Max (DSC) | - |
Trailer Fee Max (NL) | - |
Trailer Fee Max (LL) | - |
Try Fund Library Premium
For Free with a 30 day trial!